New original derivatives are described of 5-pentylamino -5-oxopentanoic and 4-pentylamino-4-oxobutanoic acids having the formula: ##STR1## in which n is 1 or 2, R.sub.1 is selected from the groups 2-naphthyl, 2 (or 3)-quinolinyl, 2 (or 3)-indolyl, 2 (or 3)-benzofuranyl, 2 (or 3)-benzothiophenyl, and R.sub.2 is a pentyl group or an alkoxyalkyl group with 4 or 5 carbon atoms, preferably pentyl, 2-ethoxyethyl, 3-methoxypropyl or 3-ethoxypropyl. The compounds have a powerful antagonistic activity towards cholecystokinin and are particularly useful in the treatment of illnesses of the digestive system, such as colitis, biliary diskinesia, pancreatitis or in the treatment of disorders of the central nervous system imputable to deficiencies in the physiological neuron levels of cholecystokinin or other related bioactive polypeptides.
                            本文介绍了5-戊基
氨基-
5-氧代戊酸和4-戊基
氨基-4-氧代
丁酸的新原始衍
生物,其
化学式为:##STR1## 其中n为1或2,R.sub.1选自2-
萘基,2(或3)-
喹啉基,2(或3)-
吲哚基,2(或3)-
苯并呋喃基,2(或3)-
苯并噻吩基,R.sub.2为戊基或具有4或5个碳原子的烷氧基烷基,优选为戊基,
2-乙氧基乙基,
3-甲氧基丙基或3-乙氧基丙基。这些化合物对胆囊收缩素具有强大的拮抗作用,特别适用于治疗消化系统疾病,如结肠炎,胆道运动障碍,胰腺炎或由于胆囊收缩素或其他相关
生物活性
多肽的生理神经元
水平不足引起的中枢神经系统疾病的治疗。